Revolution Medicines, Inc. (RVMD)
192.63
-0.89
(-0.46%)
USD |
NASDAQ |
Oct 15, 10:02
Revolution Medicines Total Long Term Debt (Quarterly) : 1.174B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.174B |
| March 31, 2026 | 420.66M |
| December 31, 2025 | 410.68M |
| September 30, 2025 | 142.14M |
| June 30, 2025 | 119.70M |
| March 31, 2025 | 121.36M |
| December 31, 2024 | 122.97M |
| September 30, 2024 | 78.31M |
| June 30, 2024 | 79.08M |
| March 31, 2024 | 79.86M |
| December 31, 2023 | 80.58M |
| September 30, 2023 | 57.09M |
| June 30, 2023 | 57.54M |
| March 31, 2023 | 57.68M |
| December 31, 2022 | 57.43M |
| September 30, 2022 | 58.18M |
| Date | Value |
|---|---|
| June 30, 2022 | 58.92M |
| March 31, 2022 | 59.58M |
| December 31, 2021 | 60.42M |
| September 30, 2021 | 26.83M |
| June 30, 2021 | 27.57M |
| March 31, 2021 | 28.29M |
| December 31, 2020 | 29.01M |
| September 30, 2020 | 29.73M |
| June 30, 2020 | 30.44M |
| March 31, 2020 | 7.553M |
| December 31, 2019 | 0.172M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.147M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Moderna, Inc. | 1.266B |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Intellia Therapeutics, Inc. | 50.07M |
| Twist Bioscience Corp. | 84.96M |
| Beam Therapeutics, Inc. | 232.15M |